EyeWorld Magazine: February 2008:
According to this report:
“Chronic use of timolol-containing topical glaucoma therapy preparations in glaucoma patients is associated with an increased risk for the development of nasolacrimal duct obstruction.”
According to this report:
“Chronic use of timolol-containing topical glaucoma therapy preparations in glaucoma patients is associated with an increased risk for the development of nasolacrimal duct obstruction.”
No comments:
Post a Comment
Leave a Comment or Question: